Risser Eric Blasius 4

What Happened Eric B. Risser, President, CEO and Director of Macrogenics, converted vested restricted stock units (RSUs) into common shares on Feb 7–8, 2026. He had 6,668 RSUs convert on Feb 7 and 11,166 RSUs convert on Feb 8 (total 17,834 shares). To cover tax withholding, 2,575 shares were withheld on Feb 7 (valued at $1.81/share = $4,661) and 4,311 shares were withheld on Feb 8 (valued at $1.81/share = $7,803), for a total of 6,886 shares withheld and ~$12,464 remitted. Net shares added to his holdings from these conversions: 10,948.

Key Details

• Transaction dates: Feb 7, 2026 and Feb 8, 2026.
• Conversions: 6,668 and 11,166 RSUs converted to shares (codes M = exercise/conversion of derivative).
• Tax withholding: 2,575 and 4,311 shares withheld at $1.81/share (codes F = payment of tax liability), totaling $4,661 and $7,803 respectively (~$12,464).
• Shares owned after the transactions: Not reported in this Form 4.
• Footnotes: F1 notes RSUs convert one-for-one into stock. F2/F3 show these RSUs came from prior grants (20,000 RSUs granted Feb 7, 2025 vesting in three installments; 33,500 RSUs granted Feb 8, 2024 vesting in three installments).
• Filing date: Form 4 filed Feb 10, 2026 covering Feb 7–8 transactions (filing timeliness not flagged in the provided data).

Context These were vesting/conversion events (receipt of award), not open-market purchases or voluntary sales. The withheld shares represent a common "sell-to-cover" method to satisfy tax withholding when RSUs vest. Code M indicates conversion/exercise of a derivative (here RSUs per the footnote) and code F indicates shares withheld to pay tax liabilities. Such conversions are routine for equity-compensated executives and do not by themselves indicate a buy or sell decision in the public market.